介入治疗术后肝脏胆汁瘤的治疗分析

Hepatic biloma after minimally invasive interventional therapies:treatment and outcomes

目的探讨肝脏微创介入治疗术后形成胆汁瘤的治疗方法。方法回顾分析2013年1月至2018年12月连续在江南大学附属医院(无锡三院)接受介入治疗的肝脏疾病患者资料。筛选术后随访证实的胆汁瘤患者,总结胆汁瘤的分类和治疗。结果共筛选出43例胆汁瘤患者,其中14例需要治疗,男性9例,女性5例,平均年龄61(29~85)岁。根据治疗方法和部位不同将胆汁瘤分为:肝外胆汁瘤(2例),行经皮胆道引流术;单纯性胆汁瘤(10例),行经皮胆汁瘤引流术;感染性胆汁瘤(2例),同时行经皮胆道引流术及经皮胆汁瘤引流术。结论胆汁瘤是肝脏疾病介入治疗术后的一种并发症,将其分类指导治疗,以期提高疗效。

Objective To study the treatment and outcomes of hepatic biloma after minimally invasive interventional therapies.Methods From January 2013 to December 2018,patients who underwent transcatheter arterial chemoembolization,percutaneous microwave ablation,and percutaneous biliary drainage(PTBD)at the Affiliated Hospital to Jiangnan University(Wuxi No.3 Hospital)and developed postoperative biloma that required treatment were included into this study.Results Of 43 bilomas,14 were treated with percutaneous drainage.There were 9 males and 5 females,with an average age of 61(29-85)years.These bilomas could be classified into the following 3 types:extrahepatic bilomas(2 patients),simple bilomas(10 patients)and infected bilomas(2 patients).The treatments included PTBD,drainage of percutaneous biloma or a combination of both.Conclusion Biloma is a known complication after minimally invasive interventional therapies.These bilomas could be classified to guide treatment and to improve prognosis.